Ruimin Hong Selected Research

Ruimin Hong Research Topics

7	Neoplasms (Cancer) 04/2024 - 01/2021
5	Hematologic Neoplasms (Hematological Malignancy) 04/2024 - 01/2021
5	Cytokine Release Syndrome 03/2024 - 01/2021
5	Multiple Myeloma 01/2023 - 01/2021
3	Leukemia 04/2024 - 01/2022
3	Infections 04/2024 - 01/2023
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 10/2020
2	Cytopenia 01/2023 - 01/2021
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 01/2021
1	Disease Progression 04/2024
1	Fever (Fevers) 03/2024
1	Carcinogenesis 06/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023
1	Critical Illness (Critically Ill) 01/2023
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2023
1	Residual Neoplasm 01/2023
1	Lymphoma (Lymphomas) 01/2021
1	COVID-19 01/2021
1	Cauda Equina Syndrome 01/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021
1	Composite Lymphoma 01/2018

16	Chimeric Antigen ReceptorsIBA 04/2024 - 10/2020
3	CytokinesIBA 03/2024 - 01/2021
3	B-Cell Maturation AntigenIBA 01/2023 - 01/2021
3	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2021
1	Proteins (Proteins, Gene)FDA Link 04/2024
1	Lysine (L-Lysine)FDA Link 04/2024
1	MethyltransferasesIBA 04/2024
1	tocilizumab (atlizumab)FDA Link 06/2023
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023
1	Circulating Tumor DNAIBA 01/2021
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021
1	NF-kappa B (NF-kB)IBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	Lenalidomide (CC 5013)FDA Link 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021

14	Therapeutics 04/2024 - 01/2018
3	Hematopoietic Stem Cell Transplantation 04/2024 - 01/2018
3	Drug Therapy (Chemotherapy) 04/2024 - 01/2018
2	Immunotherapy 01/2022 - 01/2021
1	Aftercare (After-Treatment) 01/2023
1	Immunomodulation 01/2018